Defined Term Section. Acceptable Confidentiality Agreement 10.2 Acquisition Agreement 5.2(b) Action 10.2 Affiliates 10.2 Agreement Preamble Anti-Corruption Laws 3.8(b) Applicable SAP 10.2 Articles of Incorporation 3.2(d) Book-Entry Shares 2.1(a) Business Day 10.2 CARES Act 10.2 Certificates 2.1(a) 51 Chosen Courts 9.10 Closing 1.2 Closing Confirmation 6.3(a) Closing Date 1.2 Code 10.2 Common Stock 3.4(a) Company Preamble Company Board 3.2(a) Company Disclosure Letter Article III Company ESOP 6.9(h) Company Options 3.4(a) Company Permits 3.8(a) Company Plan 3.12(a) Company Recommendation 3.2(c) Company Restricted Stock Unit 2.3(a) Company SEC Documents 3.5(a) Company Stock Plan 10.2 Confidentiality Agreement 10.2 Continuing Employees 6.9(a) Contract Employees 6.9(b) Covered Employees 3.12(a) COVID‑19 10.2 COVID‑19 Measures 10.2 Effective Time 1.3 Encumbrance 10.2 Environmental Laws 10.2 Environmental Permits 10.2 ERISA 3.12(a) ERISA Affiliate 3.12(b)(vi) ERISA Group 3.12(b)(vi) Escrow Account 2.2(a) ESOP Freeze Date 6.9(h) Exchange Act 3.3(a) Financial Advisor 3.17 Financial Statements 3.5(a) GAAP 3.5(a) Governmental Entity 3.3(a) ICC CIC Agreement 6.9(i) Indebtedness 10.2 Indemnified Liabilities 6.7(a) Indemnified Parties 6.7(a) Insurance Contract 10.2 Insurance Law 10.2 Insurance Regulator 10.2 Intellectual Property Rights 10.2 Investment Advisers Act 3.26 Investment Company Act 3.26 IRS 10.2 Knowledge 10.2 Law 10.2 Leased Real Property 10.2 Material Adverse Effect 10.2 Material Contract 3.9(a) Materials of Environmental Concern 10.2 Maximum Premium 6.7(b) Merger 1.1 Merger Consideration 2.1(a) Merger Sub Preamble Nasdaq 3.3(a)(iv)(C) Order 10.2 Outside Date 8.1(b)(i) Owned Real Property 10.2 Parent Preamble Parent Employers 6.9(a) Parent Owned Shares Recitals Paying Agent 2.2(a) Payment Fund 2.2(a) Pennsylvania Law 1.1 Permitted Encumbrances 10.2 Person 10.2 Post-Closing Plan 6.9(e) Post-Closing Welfare Plan 6.9(f) Preferred Stock 3.4(a) Producers 3.21 Proxy Statement 3.10 Real Property Leases 3.13(c) Representatives 5.2(a) Required Insurance Approvals 7.1(b) Restraints 7.1(c) Restriction 6.3(d) Rights 3.4(a) SEC 10.2 Securities Act 3.5(a) Shareholder Approval 3.2(b) Shares Recitals Site 10.2 SOX 3.5(a) Special Meeting 6.2(a) Statement of Merger 1.3 Statutory Statements 3.18(a) Shareholder Approval 3.2(b) Subsidiary 10.2 Superior Proposal 10.2 Surviving Corporation 1.1 Takeover Proposal 10.2 Takeover Statute 3.19 Tax 10.2 Tax Return 10.2 Transactions 2.2(e) Unlicensed Per...
Defined Term Section. Amalco Section 1.1(a) Arrangement Section 1.3(a)(i) Arrangement Resolution Recitals Articles of Arrangement Section 1.3(f) Bankruptcy and Equity Exception Section 2.4 Business Day Section 7.11 Canadian Proceedings Section 2.24 CBCA Section 1.3(a) Change in Recommendation Section 4.8(a) Closing Section 1.9(a) Closing Date Section 1.9(a) Code Section 2.7(h) commercially reasonable efforts Section 7.11 Company Preamble Company Arrangement Amount Section 7.11 Company Circular Section 7.11 Company Common Shares Recitals Company Contract Section 7.11 Company Debt Instruments Section 1.3(b) Company Deferred Share Units Section 7.11 Company Disclosure Schedule ARTICLE II Company DSU Plan Section 1.2 Company Employee Benefit Plans Section 2.13(a) Company ERISA Affiliate Section 2.13(a) Company Financial Statements Section 2.6(a) Company Indenture Section 7.11 Company Initial Shares Section 7.11 Company Intellectual Property Section 2.15(a) Company Labor Contracts Section 2.14(a) Company Meeting Section 1.3(b) Defined Term Section Company Non-US Benefit Plan Section 2.13(l) Company’s Ordinary Course of Business Section 7.11 Company Outstanding Amount Section 7.11 Company Permits Section 2.10 Company Preferred Shares Section 1.3(b) Company Preferred Shares Redemption Section 1.3(c) Company Preferred Shares Redemption Date Section 1.3(c) Company Recent Balance Sheet Section 2.6(a) Company Requisite Shareholder Vote Section 2.4 Company Restricted Share Units Section 7.11 Company Rights Agreement Section 2.23 Company RSU Plan Section 1.2 Company’s Costs Section 6.2(f) Company Securities Reports Section 2.22(b) Company Warrant Cancellation Section 7.11 Company Warrants Section 7.11 Confidentiality Agreement Section 4.18 Consent Agreement Section 4.3(d) Contract Section 7.11 Court Recitals Debt Commitment Letter Section 3.22 Debt Financing Section 4.4(a) Director Section 1.3(f) Dissent Rights Section 7.11 Effective Price Section 7.11 Effective Time Section 7.11 Employee Benefit Plans Section 7.11 Environmental Laws Section 2.12(a) Equity Interests Section 7.11 Equity Payment Amounts Section 7.11 vi Defined Term Section ERISA Section 7.11 ERISA Affiliate Section 7.11 Escrowed Shares Section 7.11 Exchange Act Section 1.4(b) Final Order Section 7.11 Financing Parties Section 4.4(b) Form S-4 Section 7.11 General Developments Section 7.11 Governmental Entity Section 7.11 Hazardous Substance Section 7.11 HSR Act Section 2.2 Indemnified Parties Section 4.11(a) Intellectual Prope...
Defined Term Section. 1940 Act 15(a) Act 1 Advisers Act 15(a) Affiliate 14(c) Agreement Preamble CEAct 8(e) Certificate of Limited Partnership 1 CFTC 3 Charter Series Partnership(s) 10(b) Code 7(c)(4) Commodity Broker 6 Customer Agreement 8(b) Determination Date 7(b) Exchange Agreement and Power of Attorney 10(c) Exchange Date 10(c) Futures Interests 3 General Partner Preamble Initial Closing 6 Initial Offering 6 Limited Partners Preamble Management Agreement 8(b) NASAA Guidelines 5 Net Asset Value 7(d)(2) Net Assets 7(d)(1) NFA 6 Non-Series Exchange 10(b) Partners Preamble Partnership 1 Prospectus 6 Pyramiding 8(c)(5) Redemption 10(b) Redemption Date 10(b) Request for Redemption 10(b) SEC 5 Selling Agent 6 Series Exchange 10(c) Special Redemption Date 9 Trading Advisor 6 Trading Profits 7(e) Transaction Fees and Costs 7(e) Unit(s) of General Partnership Xxxxxxxx 0 Xxxx(x) 0
Defined Term Section. Company Stockholder Approval Section 4.05(a) Company Stockholders Recitals Company Stockholders’ Meeting Section 6.04(b) Company Tax Opinion Section 7.03(e) Confidentiality Agreement Section 6.05 D&O Insurance Section 6.08(b) DGCL Recitals DOJ Section 6.09(b) DOL Section 4.12(b) DTC Section 3.02(c) Effective Time Section 2.03 ERISA Section 4.12(a) ERISA Affiliate Section 4.12(e) Exchange Agent Section 3.02(a) Exchange Fund Section 3.02(a) Exchange Ratio Section 3.01(b) Foreign Corrupt Practices Act Section 4.24(a) Foreign Plans Section 4.12(a) Form S-4 Section 5.06(b) FTC Section 6.09(b) Indemnified Party Section 6.08(a) Intervening Event Section 6.06(e) IRS Section 4.12(b) Letter of Transmittal Section 3.02(c) Material Contract Section 4.17(a) Maximum Amount Section 6.08(b) Merger Recitals Merger Consideration Recitals Merger Shares Section 3.01(b) Merger Sub Preamble Notice Period Section 6.06(d) OFAC Section 4.24(a) Outside Date Section 8.01(b) Parent Preamble Parent Common Stock Recitals Parent Financial Statements Section 5.03(a) Parent Preferred Shares Section 4.04(a) Parent Tax Opinion Section 7.02(e) PBGC Section 4.12(b) Permits Section 4.07(b) Plan Section 4.12(a) Proxy Statement Section 4.25 Surviving Corporation Recitals Termination Date Section 8.01 Uncertificated Company Shares Section 3.02(c)
Defined Term Section. Exchange Fund 2.2(a) GAAP 8.14(a) Governmental Entity 3.3(b)(vii) Hazardous Substance 3.7(c) HSR Act 3.3(b)(iii) Indebtedness 8.14(a) Indemnification Agreements 5.9(a) Intellectual Property 3.14(c) knowledge 8.14(a) Law 3.6(a) Laws 3.6(a) Leased Real Properties 3.15(b) Licenses 3.14(b) Lien 3.3(c)(i) Material Lease 3.3(d)(ii) Measurement Date 3.2(c) Merger First Recital Merger Consideration 2.1(a) Merger Sub Introduction NASDAQ 3.3(b)(vi) New Plans 5.5(b)(iv) Old Plans 5.5(b)(iv) Option and Stock-Based Award Consideration 2.2(a)(ii) Other Incentive Awards 3.2(c)(iii) Owned Real Properties 3.15(a) Parent Introduction Parent Approvals 4.2(b) Parent Disclosure Schedule Introductory paragraph to Article IV Parent Material Adverse Effect 4.1 PARSUs 5.5(a)(ii) Paying Agent 2.2(a) Defined Term Section Permitted Lien 3.3(c)(i) person 8.14(a) principal executive officer 3.4(d) principal financial officer 3.4(d) Property Encumbrances 3.15(a) Proxy Statement 3.11 Qualifying Transaction 7.2(a)(i)(A) Real Properties 3.15(b) Recommendation 3.3(a) Regulatory Law 5.6(d) Representatives 5.2(a) Restricted Stock 5.5(a)(ii) SEC 3.4(a) Securities Act 3.3(b)(iv) Share 2.1(a) Software 3.14(f) SOX 3.4(d) Subsidiaries 8.14(a) Superior Proposal 5.3(g) Surviving Corporation 1.1 Tax Return 3.12(c)(ii) Taxes 3.12(c)(i) Termination Date 5.1(a)
Defined Term Section. Share Loan and Acquisition Agreements 2.3(b) Shareholder Approvals 3.5(a) Sonterra Right of First Offer Agreement 1.2(e) Spin-Off 1.2 Springing Shares 2.3(b) Subsidiary 2.2(a) Superior Acquisition Proposal 4.1 Surviving Trust 1.1 Takeover Statute 2.19 Taxes 2.13(a) Third Party Management Agreements 2.17(d) Title 8 1.1 to the Knowledge of EQR 3.21 to the Knowledge of Wellsford 2.25 Transaction Costs Agreement 5.4 Transfer and Gains Taxes 5.9 Wellsford Preamble Wellsford Benefit Plans 2.11(a) Wellsford Common Shares 1.2(f) Wellsford Disclosure Letter Article 2 Wellsford Financial Statement Date 2.6 Wellsford Material Adverse Change 2.6 Wellsford Material Adverse Effect 2.1 Wellsford Options 2.3(b) Wellsford Properties 2.8(a) Wellsford SEC Documents 2.5 Wellsford Series A Preferred Shares 2.3(a) Wellsford Series B Preferred Shares 2.3(a) Wellsford Shareholder Approvals 2.4(a) Wellsford Shareholder Meeting 5.1(c) Wellsford Subsidiaries 2.2 WPHC 1.10 WPHC Non-Voting Shares 5.24 WPHC Voting Shares 5.24 AGREEMENT AND PLAN OF MERGER ---------------------------- THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") dated as of January 16, 1997 by and between EQUITY RESIDENTIAL PROPERTIES TRUST, a Maryland real estate investment trust ("EQR"), and WELLSFORD RESIDENTIAL PROPERTY TRUST, a Maryland real estate investment trust ("Wellsford").
Defined Term Section. JDC Proposal Notice 5.1 Joint Commercialization Committee 2.3 Joint Development Committee 2.2 Joint Inventions 10.1.2(a) Joint Know-How 10.1.1 Joint Manufacturing Subcommittee 7.5 Key Milestone 3.5 Label Expansion 5.1 Liabilities 13.1 Liabilities for an Intrinsic Defect 13.4 Loan 6.4.1(b) Milestone 6.2.3 NDA Initiation 8.1.1 Negotiating Party 2.2.1(l) New Compound License 5.4 New Compound Negotiation Period 5.4 Non-VCM Improvements 9.5.2 Notice Date 15.5.3(a)(i) Notice Period 15.5.3(a)(i) Other Formulation 5.1 Otsuka Introduction Otsuka Indemnitees 13.1 Otsuka Inventions 10.1.2(a) Parties Introduction Party Introduction Patent Infringement Claim 10.3.2 Patent Prosecution Plan 2.2.1(o) Paying Party 6.3.6 Permitted Overrun 6.6 Pharmacovigilance Agreement 8.4 Phase II Costs 6.4.1(a) Phase III Costs 6.4.1(a) Preexisting Product 2.1.2 * Confidential Treatment Requested. Execution Copy Defined Term Section Product Infringement Claim 10.4 Product Recall Expenses 8.5 Product Withdrawal Expenses 8.6 Promissory Note 6.4.1(b) Providing Party 9.7.3 Receiving Party 9.7.3 Research Cost 5.5.4(a) Research Plan 5.5.1 Research Program Term 5.5.4(a) Responding Party 6.9.2 Royalty for Shared Territory 6.3.2 Royalty for Sole Territory 6.3.1
Defined Term Section. Final August Balance Sheet 2.11(c) Former Optionholder 2.2(c)(ii) Former Optionholder Payment Condition 2.2(c)(ii)(1) Former Optionholders 2.2(c)(ii) Governmental Permits 3.14(b) HSR Filing 5.3(a) indebtedness 4.7 indemnified party 9.4 indemnifying party 9.4 Information Statement 5.4(a) Intellectual Property Licenses 3.13(b) Key Employees Recitals Letter of Transmittal 2.5(a) Merger Recitals Merger Election Notice 2.1 Merger Option Recitals Merger Sub Preamble NDA 5.7 Non-Competition Agreement Recitals Option Termination Agreement Recitals Option Termination Information Statement 5.4(b) Pre-Closing Admitted Claim 9.5(b) Pre-Closing Resolved Claim 9.5(b) Preliminary August Balance Sheet 2.11(c) product candidates 3.14(d) Qualified Former Optionholder/Bonus Recipient Definitions Release Date 2.8(a) Representative Preamble Defined Term Section Representative Expense Funds 2.8(d) Representative Expenses 2.8(d) Representative Losses 2.9(c) Resolved Claim 2.8(c) Reversion Amount 2.2(c)(ii)(1) Supporting Stockholder Recitals Supporting Stockholder Option Agreement Recitals Stockholder Approvals 3.3(d)(ii) Surviving Corporation Recitals Unresolved Claims 2.8(e)
Defined Term Section. Action Section 1.1(1) Affiliate Section 1.1(2) Allegion Asset Transferee Section 1.1(3) Allegion Assets Section 1.1(4) Agreement Preamble Agreement Disputes Section 8.1
Defined Term Section. Merger Closing Recitals Merger Closing Date Section 1.4(a) Merger Sub Recitals Merger Transaction Recitals Multiemployer Plan Section 3.11(d) New Securities Issuance Section 7.7(a) PIPE Investment Recitals Prospectus Section 9.2(a)(ii) Purchase Price Section 1.3 Registrable Securities Section 7.3(a) Registration Period Section 7.3(d)(i) Resale Registration Statement Section 7.3(a) SEC SPAC Accounting Changes Section 2.13(d) Sponsor Preamble Subscription Agreements Recitals Suspension Event Section 7.3(e) Transaction Recitals Transaction Documents Recitals Trust Agreement Section 2.8 Trustee Section 2.8 Underlying Shares Section 1.6 Union Section 3.14(g) Year End Financial Statements Section 3.4(a) EXHIBIT C Form of Convertible Note AGREED FORM THE SALE OF THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT, AS AMENDED OR APPLICABLE STATE SECURITIES LAWS. THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO ITS DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SALE OF THIS SECURITY (INCLUDING ANY SECURITIES ISSUABLE UPON CONVERSION) UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, OR AN EXEMPTION THEREFROM. THIS NOTE HAS BEEN ISSUED WITH “ORIGINAL ISSUE DISCOUNT” (WITHIN THE MEANING OF SECTION 1272 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED). UPON WRITTEN REQUEST (ADDRESSED TO [●] AT UNITED HOMES GROUP, INC., 00 X XXXXX XXXXX XXXXX, XXXX, XXXXX XXXXXXXX 00000), THE ISSUER WILL PROMPTLY MAKE AVAILABLE TO ANY HOLDER OF THIS NOTE THE FOLLOWING INFORMATION: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE; (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE; AND (3) THE YIELD TO MATURITY OF THE NOTE. UNITED HOMES GROUP, INC. SENIOR CONVERTIBLE PROMISSORY NOTE $[•] [●], 2023 FOR VALUE RECEIVED, United Homes Group, Inc., (formerly known as DiamondHead Holdings Corp.) a corporation organized under the Laws of the state of Delaware (the “Issuer”), HEREBY promises to pay to the order of [Holder], or its registered assigns (the “Holder”), the principal sum of [•] U.S. dollars ($[•]) (the “Principal Amount”) plus the aggregate amount of accrued interest on the outstanding Principal Amount, in each case pursuant to the terms and conditions of that certain convertible note purchase agreement, dated as of March 21, 2023, by and among the Issuer, ...
